This article first appeared on GuruFocus.

Alvotech (NASDAQ:ALVO) is set to release its Q3 2025 earnings on Nov 12, 2025. The consensus estimate for Q3 2025 revenue is $118.81 million, and the earnings are expected to come in at -$0.02 per share. The full-year 2025 revenue is expected to be $594.94 million, and the earnings are expected to be $0.38 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 6 Warning Signs with ALVO.

Is ALVO fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for Alvotech (NASDAQ:ALVO) have declined from $643.05 million to $594.94 million for the full year 2025 and from $933.57 million to $870.38 million for 2026. Conversely, earnings estimates have increased from $0.34 per share to $0.38 per share for the full year 2025 and from $0.55 per share to $0.75 per share for 2026.

In the previous quarter ending June 30, 2025, Alvotech's (NASDAQ:ALVO) actual revenue was $173.34 million, which beat analysts' revenue expectations of $120.51 million by 43.84%. Alvotech's (NASDAQ:ALVO) actual earnings were $0.14 per share, surpassing analysts' earnings expectations of -$0.01 per share by 1500%. Following the release of the results, Alvotech (NASDAQ:ALVO) increased by 3.58% in one day.

Based on the one-year price targets offered by 5 analysts, the average target price for Alvotech (NASDAQ:ALVO) is $12.50, with a high estimate of $17.50 and a low estimate of $8. The average target implies an upside of 128.10% from the current price of $5.48.

Based on GuruFocus estimates, the estimated GF Value for Alvotech (NASDAQ:ALVO) in one year is $66.64, suggesting an upside of 1116.06% from the current price of $5.48.

Based on the consensus recommendation from 4 brokerage firms, Alvotech's (NASDAQ:ALVO) average brokerage recommendation is currently 2.3, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.